Novo Nordisk downgraded as pipeline 'not poised to blunt semaglutide LOE'
Go back to Novo Nordisk downgraded as pipeline 'not poised to blunt semaglutide LOE'| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 50.43 +1.66 (3.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.77 | 52 Week High | $59.00 | |||
| Open | $49.82 | 52 Week Low | $32.80 | |||
| Day High | $50.90 | P/E | N/A | |||
| Day Low | $49.78 | EPS | $0.00 | |||
| Volume | 12,080,181 | |||||
